Cost effectiveness analysis of linezolid vs. teicoplanin for the treatment of serious gram-positive bacterial infections in a multinational randomized trial

J Z  Li; R J  Willke; D A  Balan; D  Nathwani; H  Lopez; B E  Rittenhouse; M  Tavacoli; E  Mozaffari

Cost effectiveness analysis of linezolid vs. teicoplanin for the treatment of serious gram-positive bacterial infections in a multinational randomized trial

J Z Li, R J Willke, D A Balan, D Nathwani, H Lopez, B E Rittenhouse, M Tavacoli, E Mozaffari

School of Physics and Astronomy

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	259-260
Number of pages	2
Journal	Value in Health
Volume	6
Publication status	Published - May 2003

Cite this

@article{fca9e855b9754dcbbb3c88c49c569ee6,

title = "Cost effectiveness analysis of linezolid vs. teicoplanin for the treatment of serious gram-positive bacterial infections in a multinational randomized trial",

author = "Li, {J Z} and Willke, {R J} and Balan, {D A} and D Nathwani and H Lopez and Rittenhouse, {B E} and M Tavacoli and E Mozaffari",

year = "2003",

month = may,

language = "English",

volume = "6",

pages = "259--260",

journal = "Value in Health",

publisher = "ELSEVIER SCIENCE INC",

}

TY - JOUR

T1 - Cost effectiveness analysis of linezolid vs. teicoplanin for the treatment of serious gram-positive bacterial infections in a multinational randomized trial

AU - Li, J Z

AU - Willke, R J

AU - Balan, D A

AU - Nathwani, D

AU - Lopez, H

AU - Rittenhouse, B E

AU - Tavacoli, M

AU - Mozaffari, E

PY - 2003/5

Y1 - 2003/5

M3 - Article

VL - 6

SP - 259

EP - 260

JO - Value in Health

JF - Value in Health

ER -